AKT1 and cancer: DHW-208, a pan PI3K inhibitor, is a novel 4-amino-quinazoline derivative containing hydrophilic groups and suppressed the growth of cancer cells by inhibiting the PI3K/AKT/mTOR-signaling pathway (Figure 1A).